Table 1 |
|
|
Clinical and pathologic features of patients with gallbladder malignancies |
|
|
Feature of primary GB carcinoma |
N0 (Percentage) |
|
|
|
|
Clinical symptoms (abdominal pain, jaundice, nausea and vomiting, weight loss) |
5/10 (50%) |
|
|
|
|
Mass |
8/10 (80%) |
|
|
|
|
Gallstones |
9/10 (90%) |
|
|
|
|
Mass associated with gallstones |
8/9 (89%) |
|
|
|
|
Pre-op diagnosis benign diseases |
5/10 (50%) |
|
|
|
|
Pre-op diagnosis GB cancer |
2/10 (20%) |
|
|
|
|
Pre-op diagnosis bile duct tumor |
3/10 (30%) |
|
|
|
|
Malignant postoperative diagnosis |
Primary: 10/23 (43%) |
|
|
|
|
Metastasis to GB: 6/23 (26%) |
|
|
|
|
|
Bile duct carcinoma invasive into GB: 6/23 (26%) |
|
|
|
|
|
Unidentified origin carcinoma: 1/23 (5%) |
|
|
|
|
|
Giang et al. Diagnostic Pathology 2012 7:10 doi:10.1186/1746-1596-7-10 |
|
